BRCA2 and ovarian cancer: This was the first study in Vietnam to investigate mutations of BRCA1 and BRCA2 genes in breast and ovarian cancer patients with the criteria of HBOC syndrome, and to develop a risk score associated with the cohort based on carrier status and family history.